Development of an Intravitreal Peptide (BQ123) Sustained Release System Based on Poly(2-Hydroxyoctanoic Acid) Aiming at a Retinal Vasodilator Response
Marieke Veurink(University of Geneva), Constantin J. Pournaras, Arnd Heiligenhaus(Essen University Hospital), Lutz R. Asmus(University of Geneva), Michael Möller(University of Geneva), Maren Hennig(St. Franziskus Hospital), Béatrice Kaufmann(University of Lausanne), Robert Gurny(University of Geneva), Georgios Mangioris(Mayo Clinic)
Cited by 5
Related Papers
Intravitreal Ranibizumab May Induce Retinal Arteriolar Vasoconstriction in Patients with Neovascular Age-related Macular Degeneration
|Ophthalmology|2009|135
Long‐term results of the effect of intravitreal ranibizumab on the retinal arteriolar diameter in patients with neovascular age‐related macular degeneration
|Acta Ophthalmologica|2013|34
Lactate-Induced Retinal Arteriolar Vasodilation Implicates Neuronal Nitric Oxide Synthesis in Minipigs
|Investigative Ophthalmology & Visual Science|2008|27